Europe says it has enough Gilead antiviral for virus

Bloomberg

Countries including Britain, Germany and Switzerland sought to allay concerns that they won’t have sufficient stocks of Gilead Sciences Inc’s remdesivir, one of two drugs shown to treat Covid-19, after the US forged a deal to snap up almost all the supplies for three months.
The UK worked with Gilead in May to secure remdesivir in advance and has enough of the medicine to treat every National Health Service patient who needs it, officials said in an email response to questions. Switzerland has supplies of the drug set aside for seriously ill patients, according to a government spokesman.
Despite such reassurances following the US agreement
announced earlier this week, questions remain about whether some nations will have adequate supplies. The news fueled worries about countries like the US locking up access to drugs, vaccines and other pandemic essentials to place themselves in the best possible position to fight the virus.